Peripheral blood TCR clonotype diversity as an age-associated marker of breast cancer progression.
Nishida J, Cristea S, Bodapati S, Puleo J, Bai G, Patel A, Hughes M, Snow C, Borges V, Ruddy KJ, Collins LC, Feeney AM, Slowik K, Bossuyt V, Dillon D, Lin NU, Partridge AH, Michor F, Polyak K. Peripheral blood TCR clonotype diversity as an age-associated marker of breast cancer progression. Proc Natl Acad Sci U S A. 2023 Dec 05; 120(49):e2316763120.
-
Aged
-
Biomarkers, Tumor
-
Breast Neoplasms
-
Carcinoma, Ductal, Breast
-
Carcinoma, Intraductal, Noninfiltrating
-
CD8-Positive T-Lymphocytes
-
Female
-
Humans
-
Neoplastic Processes
-
Receptors, Antigen, T-Cell
-
Receptors, Antigen, T-Cell, alpha-beta